Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 640 | 1,610 | 2,000 | 460 | 330 |
| TOTAL | $640 | $1,610 | $2,000 | $460 | $330 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 410 | 1,850 | 1,500 | 910 | 810 |
| TOTAL | $410 | $1,850 | $1,500 | $910 | $810 |
| Total Assets | $1,050 | $3,460 | $3,500 | $1,370 | $1,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 70 | 150 | 0 | 0 |
| Accounts payable and accrued liabilities | 4,420 | 5,310 | 7,210 | 5,470 | 7,380 |
| Other current liabilities | 460 | 530 | 850 | 160 | 840 |
| TOTAL | $4,880 | $5,910 | $8,210 | $5,630 | $8,220 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,610 | 0 | 0 | 2,410 | 2,220 |
| TOTAL | $4,410 | $2,060 | $2,590 | $2,410 | $2,220 |
| Total Liabilities | $9,290 | $7,970 | $10,800 | $8,040 | $10,440 |
| Shareholders' Equity | |||||
| Common Shares | 80 | 780 | 750 | 700 | 610 |
| Other shareholders' equity | -4 | 230 | -890 | -80 | 0 |
| TOTAL | $366,956 | $351,870 | $335,790 | $311,820 | $302,440 |
| Total Liabilities And Equity | $376,246 | $359,840 | $346,590 | $319,860 | $312,880 |